Personalis, Inc. Common Stock (PSNL) is a publicly traded Healthcare sector company. As of July 14, 2026, PSNL trades at $15.27 with a market cap of $1.47B and a P/E ratio of -14.66. PSNL moved +1.50% today. Year to date, PSNL is +88.71%; over the trailing twelve months it is +136.11%. Its 52-week range spans $2.83 to $16.15. Analyst consensus is strong buy with an average price target of $11.67. Rallies surfaces PSNL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PSNL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $15.27 |
| Market Cap | $1.47B |
| P/E Ratio | -14.66 |
| EPS | $-1.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.15 |
| 52-Week Low | $2.83 |
| Volume | 29.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $64.52M |
| Net Income | $-95.55M |
| Gross Margin | 13.72% |
7 analysts cover PSNL: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.67.